Novartis Investigative Site — Barcelona

Public research footprint of Novartis Investigative Site, compiled from the ClinicalTrials.gov public registry.

613

Registered studies

124

Active

Recruiting now

372

Completed

113

Stopped or withdrawn

Most-studied conditions

HR+/HER2- Ductal and Lobular Breast Cancer · Primary Prevention of Atherosclerotic Cardiovascular Disease · Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive · Metastatic Castration-resistant Prostate Cancer

Recently updated registry entries

NCT06617793 — An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in… (Recruiting)
NCT05142696 — A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With… (Active Not Recruiting)
NCT05939414 — An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Novartis Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.